5-乙酰氨基异喹啉 | 27461-33-2

• 物质功能分类: 医药中间体 - 异喹啉类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 中文名称: 5-乙酰氨基异喹啉
• 英文名称: N-(isoquinolin-5-yl)acetamide
• 英文别名: 5-acetamidoisoquinoline；5-acetylaminoisoquinoline；N-isoquinolin-5-ylacetamide
• CAS: 27461-33-2
• 化学式: C₁₁H₁₀N₂O
• mdl: MFCD05981994
• 分子量: 186.213
• InChiKey: FZICVXWYDXOFAW-UHFFFAOYSA-N

物化性质

• 熔点：
  166℃
• 沸点：
  448.7±18.0 °C(Predicted)
• 密度：
  1.242±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  42
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933499090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-Acetamidoisoquinoline
Synonyms: N-(Isoquinolin-5-yl)acetamide

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-Acetamidoisoquinoline
CAS number: 27461-33-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H10N2O
Molecular weight: 186.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-乙酰氨基异喹啉 在 盐酸 、 硫酸 、 potassium nitrate 作用下， 生成 8-硝基-5-异喹啉胺
  参考文献：
  名称：

  Deamination of 5-Amino-8-nitroisoquinoline¹

  摘要：

  DOI：

  10.1021/ja01262a062
• 作为产物：
  描述：

  5-硝基异喹啉 在 乙醇 、 镍 作用下， 80.0 ℃ 、12.75 MPa 条件下， 生成 5-乙酰氨基异喹啉
  参考文献：
  名称：

  Derivatives of Aminoisoquinolines¹

  摘要：

  DOI：

  10.1021/ja01256a012

文献信息

• [EN] SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS<br/>[FR] ANALOGUES D'URÉE PONTÉS SUBSTITUÉS EN TANT QUE MODULATEURS DE SIRTUINE
  申请人：GLAXOSMITHKLINE IP NO 2 LTD

  公开号：WO2016079709A1

  公开（公告）日：2016-05-26

  The present invention relates to novel substituted bridged urea analog compounds of Formula (I) or pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, processes for making and use of such compounds, alone or in combination with other therapeutic agents, as Sirtuin Modulators useful for increasing lifespan of a cell, and for use in treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity.

  本发明涉及一种新型的取代桥式脲类似物化合物，其化学式为（I）或其药学上可接受的盐，相应的药物组合物，制备这种化合物的方法以及单独使用或与其他治疗剂联合使用的这些化合物作为Sirtuin调节剂，可用于增加细胞寿命，并用于治疗和/或预防各种疾病和紊乱，包括但不限于与衰老或压力、糖尿病、肥胖、神经退行性疾病、心血管疾病、血液凝块紊乱、炎症、癌症和/或潮红有关的疾病或紊乱，以及那些会受益于增加线粒体活性的疾病或紊乱。
• [EN] COMPOSITIONS AND METHODS FOR INHIBITING INFLUENZA RNA POLYMERASE PA ENDONUCLEASE<br/>[FR] COMPOSITIONS ET PROCÉDÉS POUR INHIBER L'ENDONUCLÉASE DE LA PA DE L'ARN POLYMÉRASE DE LA GRIPPE
  申请人：UNIV CALIFORNIA

  公开号：WO2017156194A1

  公开（公告）日：2017-09-14

  There are provided inter alia metalloenzyme inhibitors, such as inhibitors of influenza A RNA dependent RNA polymerase PA subunit endonuclease, and methods of synthesis and use of the same.

  其中提供了金属酶抑制剂，例如流感A病毒RNA依赖性RNA聚合酶PA亚基内切酶的抑制剂，以及其合成和使用方法。
• Copper-catalyzed synthesis of pyrido-fused quinazolinones from 2-aminoarylmethanols and isoquinolines or tetrahydroisoquinolines
  作者：Thao T. Nguyen、Khang X. Nguyen、Phuc H. Pham、Duc Ly、Duyen K. Nguyen、Khoa D. Nguyen、Tung T. Nguyen、Nam T. S. Phan

  DOI：10.1039/d1ob00229e

  日期：——

  Pyrido-fused quinazolinones were synthesized via copper-catalyzed cascade C(sp2)–H amination and annulation of 2-aminoarylmethanols with isoquinolines or pyridines. The transformation proceeded readily in the presence of a commercially available CuCl2 catalyst with molecular oxygen as a green oxidant. Moreover, the dehydrogenative cross-coupling of 2-aminoarylmethanols with tetrahydroisoquinolines

  通过铜催化的级联 C(sp 2 )-H 胺化和 2-氨基芳基甲醇与异喹啉或吡啶的环化合成吡啶并稠合的喹唑啉酮。在市售的 CuCl 2催化剂和分子氧作为绿色氧化剂的存在下，转化很容易进行。此外，还探索了 2-氨基芳基甲醇与四氢异喹啉的脱氢交叉偶联，其中 CuBr 表现出比 CuCl 2更高的催化活性. 在优化的反应条件下观察到广泛的底物范围和良好的功能耐受性。通过这种策略可以获得具有生物活性的天然生物碱芸香芸香碱。该协议的显着特点是复杂的杂环结构很容易在一个合成步骤中从容易获得的反应物和催化剂中获得。这种通往吡啶并融合的喹唑啉酮的途径将是对现有协议的补充。
• Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors
  申请人：——

  公开号：US20030232875A1

  公开（公告）日：2003-12-18

  Heterocyclic amide derivatives, of formula (I): wherein —X-Y-Z- is selected from —S—CR 4 ═CR 5 —, —CR 4 ═CR 5 —S—, —O—CR 4 ═CR 5 —, —CR 4 ═CR 5 —O—, —N═CR 4 —S—, —S—CR 4 ═N—, —NR 6 —CR 4 ═CR 5 — and —CR 4 ═CR 5 —NR 6 —; or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof; (with provisos); possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity. Processes for the manufacture of said heterocyclic amide derivatives and pharmaceutical compositions containing them are described.

  杂环酰胺衍生物的化学式（I）：其中—X-Y-Z-选择自—S—CR4═CR5—，—CR4═CR5—S—，—O—CR4═CR5—，—CR4═CR5—O—，—N═CR4—S—，—S—CR4═N—，—NR6—CR4═CR5—和—CR4═CR5—NR6—；或其药学上可接受的盐或体内可水解酯；（附带条件）；具有糖原磷酸化酶抑制活性，因此在治疗与糖原磷酸化酶活性增加相关的疾病状态中具有价值。描述了制备所述杂环酰胺衍生物和含有它们的药物组合物的方法。
• Photocatalytic redox-neutral hydroxyalkylation of <i>N</i>-heteroaromatics with aldehydes
  作者：Hiromu Fuse、Hiroyasu Nakao、Yutaka Saga、Arisa Fukatsu、Mio Kondo、Shigeyuki Masaoka、Harunobu Mitsunuma、Motomu Kanai

  DOI：10.1039/d0sc04114a

  日期：——

  radical, 2) cleavage of the formyl C‒H bond of the aldehyde substrates by a thiyl radical acting as a hydrogen atom transfer catalyst to generate acyl radicals, 3) Minisci-type addition of the resulting acyl radicals to N-heteroaromatics, and 4) a spin-center shift, photoredox-catalyzed single-electron reduction, and protonation to produce secondary alcohol products. This metal-free hybrid catalysis proceeded

  使用包含吖啶鎓光氧化还原催化剂和硫代磷酸有机催化剂的二元混合催化剂体系实现了N-杂芳族化合物与醛的羟烷基化。反应按照以下顺序进行：1）硫代磷酸催化剂的光氧化还原催化单电子氧化生成硫自由基，2）硫自由基作为氢裂解醛底物的甲酰基C-H键原子转移催化剂产生酰基自由基，3)将所得酰基自由基与N-杂芳族化合物进行Minisci型加成，以及4)自旋中心转移、光氧化还原催化的单电子还原和质子化以产生仲醇产物。这种无金属杂化催化在温和的条件下进行，适用于多种底物，包括异喹啉、喹啉和吡啶作为 N-杂芳族化合物，以及芳香族和脂肪族醛，并耐受各种官能团。该反应适用于药物及其先导化合物的后期衍生化。